ADHD spend to increase 13-fold

Attention-deficiency hyperactivity disorder (ADHD) drug costs for the NHS are set to soar with increased diagnosis of the condition in children and adolescents in the UK, claim German researchers.

The estimated £7 million spend on ADHD by the NHS in 2002 is expected to rise to between £49 and £101 million a year by 2012. The overall drug expenditure by individual doctors for ADHD may increase nine-fold.

Professor Michael Schlander, from the University of Heidelberg calculated the range of possible costs by considering likelihood of diagnosis and treatment, the level of treatment and drug costs.

The calculation is based on the assumption that ADHD has, until recently, been undiagnosed in the UK. In turn, the number of scrips for ADHD drugs has increased.

A BBC Panorama programme led to reports that the drugs offer no long-term benefit.

These claims were based on a three-year follow-up study that showed little difference between children with ADHD managed with drugs and those given behavioural or routine care.

Have you registered with us yet?

Register now to enjoy more articles and free email bulletins

Register

Already registered?

Sign in

Follow Us:

Just published

Locum GPs left behind in patchy COVID-19 vaccine rollout

Locum GPs left behind in patchy COVID-19 vaccine rollout

COVID-19 vaccination for locum GPs has trailed behind the rollout to other doctors,...

Four in five over-80s have had first COVID-19 jab despite weekend slump in vaccinations

Four in five over-80s have had first COVID-19 jab despite weekend slump in vaccinations

Almost 80% of people aged over 80 in the UK have have had at least one dose of COVID-19...

Fitness to practise and revalidation to continue despite pandemic, GMC confirms

Fitness to practise and revalidation to continue despite pandemic, GMC confirms

Revalidation and ongoing fitness to practise cases will continue despite huge pressure...

UK COVID-19 vaccination programme tracker

UK COVID-19 vaccination programme tracker

GPs across the UK are playing a leading role in the largest-ever NHS vaccination...

Supporting men and children experiencing domestic violence through general practice

Supporting men and children experiencing domestic violence through general practice

IRIS is an evidence-based programme designed to reach female survivors of domestic...

Learn about neurological aspects of 'long COVID' at a MIMS Learning webinar

Learn about neurological aspects of 'long COVID' at a MIMS Learning webinar

Loss of taste and smell and neurological aspects of 'long COVID' infection will be...